Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
Molecular Cancer Therapeutics
|
June 16, 2005
Identification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine-resistant cancer cells
Kurtis E Bachman, Jason Sager, Ian Cheong, et al.
Molecular Cancer Therapeutics
|
May 20, 2016
Concomitant Inhibition of PI3Kβ and BRAF or MEK in PTEN-Deficient/BRAF-Mutant Melanoma Treatment: Preclinical Assessment of SAR260301 Oral PI3Kβ-Selective Inhibitor
Hélène Bonnevaux, Olivier Lemaitre, Loic Vincent, et al.
Gastroenterology
|
June 10, 2006
Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options
Eike Gallmeier, Eric S Calhoun, Carlo Rago, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2003
PRL-3 expression in metastatic cancers
Alberto Bardelli, Saurabh Saha, Jason A Sager, et al.
Oncotarget
|
December 24, 2010
PI3Kα inhibitors that inhibit metastasis
Oleg Schmidt-Kittler, Jiuxiang Zhu, Jian Yang, et al.
Cell Cycle (Georgetown, Tex.)
|
January 30, 2009
Single-vector inducible lentiviral RNAi system for oncology target validation
Dmitri Wiederschain, Susan Wee, Lin Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2009
Crystal structure of human CDK4 in complex with a D-type cyclin
Philip J Day, Anne Cleasby, Ian J Tickle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2018
Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors
Yemarshet K Gebreyohannes, Agnieszka Wozniak, Madalina-Elena Zhai, et al.
Cancer Research
|
June 10, 2010
The Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells
Zainab Jagani, Dmitri Wiederschain, Alice Loo, et al.
Nature Medicine
|
February 22, 2005
Contribution of bone marrow-derived endothelial cells to human tumor vasculature
Brock A Peters, Luis A Diaz, Kornelia Polyak, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
Molecular Cancer Therapeutics
|
June 16, 2005
Identification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine-resistant cancer cells
Kurtis E Bachman, Jason Sager, Ian Cheong, et al.
Molecular Cancer Therapeutics
|
May 20, 2016
Concomitant Inhibition of PI3Kβ and BRAF or MEK in PTEN-Deficient/BRAF-Mutant Melanoma Treatment: Preclinical Assessment of SAR260301 Oral PI3Kβ-Selective Inhibitor
Hélène Bonnevaux, Olivier Lemaitre, Loic Vincent, et al.
Gastroenterology
|
June 10, 2006
Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options
Eike Gallmeier, Eric S Calhoun, Carlo Rago, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2003
PRL-3 expression in metastatic cancers
Alberto Bardelli, Saurabh Saha, Jason A Sager, et al.
Oncotarget
|
December 24, 2010
PI3Kα inhibitors that inhibit metastasis
Oleg Schmidt-Kittler, Jiuxiang Zhu, Jian Yang, et al.
Cell Cycle (Georgetown, Tex.)
|
January 30, 2009
Single-vector inducible lentiviral RNAi system for oncology target validation
Dmitri Wiederschain, Susan Wee, Lin Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2009
Crystal structure of human CDK4 in complex with a D-type cyclin
Philip J Day, Anne Cleasby, Ian J Tickle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2018
Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors
Yemarshet K Gebreyohannes, Agnieszka Wozniak, Madalina-Elena Zhai, et al.
Cancer Research
|
June 10, 2010
The Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells
Zainab Jagani, Dmitri Wiederschain, Alice Loo, et al.
Nature Medicine
|
February 22, 2005
Contribution of bone marrow-derived endothelial cells to human tumor vasculature
Brock A Peters, Luis A Diaz, Kornelia Polyak, et al.
Page
of 8